Welcome to our dedicated page for Astronics SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astronics Corporation (ATRO) filings document the company's aerospace, defense and mission-critical technology business, including periodic operating updates furnished on Form 8-K. These reports cover financial results, preliminary revenue, bookings, backlog, outlook, segment commentary for Aerospace and Test Systems, and Regulation FD investor presentation materials.
The company's SEC record also includes proxy materials covering annual meeting matters and corporate governance. Material-event filings describe capital-structure and financing actions, including a revolving credit agreement, convertible senior notes, capped call transactions, repurchases of prior convertible notes, and related debt terms that support Astronics' operating and acquisition activity.
West Fay reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Fay West received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for service as a director. The shares were awarded on February 19, 2026 at no stated purchase price, increasing West’s directly owned holdings to 7,588 shares.
FRISBY JEFFRY D reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp director Jeffry D. Frisby received a stock bonus award of 1,533 common shares on February 19, 2026 as compensation for his board service. After this grant, he directly owns 47,056 Astronics common shares, reflecting equity-based compensation rather than an open-market share purchase.
MORAN MARK J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Mark J. Moran received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for his board service. The award was granted at no cash cost and increases his directly owned stake to 44,056 shares.
Mulato James reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp reported that James Mulato, President of Astronics Test Systems, received a grant of 7,675 restricted stock units on February 19, 2026 at no cash cost. Each unit represents the right to receive one share of common stock at settlement.
The filing explains that vesting of these restricted stock units depends on Astronics Corp's average annual adjusted EBITDA over specified multi‑year periods. Between 50% and 150% of the applicable target unit amounts may vest on future February dates, with the actual vesting percentage determined by the company’s performance.
Capital International Investors has filed a Schedule 13G reporting a passive ownership stake in Astronics Corp. common stock. The firm is deemed to beneficially own 1,849,886 shares, representing 5.9% of Astronics’ 31,619,410 shares believed to be outstanding as of the reported date.
The filing states Capital International Investors has sole voting and dispositive power over all 1,849,886 shares and no shared power. It also certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astronics.
American Century Investment Management and related entities reported a significant ownership position in Astronics Corporation. They disclosed beneficial ownership of 1,764,235 shares of Astronics common stock, representing 5.6% of the outstanding class as of December 31, 2025.
American Century and its parent American Century Companies, Inc., together with the Stowers Institute for Medical Research, reported sole voting power over 1,453,455 shares and sole dispositive power over 1,764,235 shares, with no shared voting or dispositive power. They certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
State Street Corporation has disclosed a significant ownership position in Astronics Corp common stock. It reports beneficial ownership of 1,832,179 shares, representing 5.8% of Astronics’ common stock as of 12/31/2025.
State Street has shared voting power over 1,755,956 shares and shared dispositive power over 1,832,179 shares, with no sole voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
Astronics Corporation filed a current report to note that on February 5, 2026 it issued a news release announcing preliminary unaudited adjusted EBITDA margins for the fourth quarter and full year of 2025. The company also highlighted plans to webcast its presentations at the TD Cowen Aerospace & Defense Conference.
BlackRock, Inc. has filed an amended Schedule 13G showing a significant passive stake in Astronics Corp common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 2,749,452 shares, representing 8.7% of the outstanding common stock. BlackRock has sole voting power over 2,701,240 shares and sole dispositive power over all 2,749,452 shares, with no shared voting or dispositive power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of Astronics’ outstanding common shares.